We started Cleerly with the intent to make a comprehensive care pathway for evaluation education, treatment and tracking for heart disease.,” Founder and CEO Jim Min, MD explains to Bloomberg ...

Cleerly is aiming to further expand that repository with its ongoing studies, which plan to enroll more than 100,000 patients from across the globe within the next decade. Related.

Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company’s AI software aims to identify early-stage coronary ...

Cleerly has claimed an additional $106 million in funding to boost the reach of its artificial intelligence programs for cardiovascular imaging as it aims to capitalize on recent gains in | Led by ...

Cleerly has announced interim results from a trial, described as the largest-ever cardiovascular phenotype outcomes study, finding that women living with chronic coronary artery disease (CAD) are ...

Cleerly has concluded a $106m Series C funding round to advance its AI-driven coronary artery disease (CAD) platform. The US-based digital healthcare company’s non-invasive AI-Quantitative ...

Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25. Cleerly, the leader in cardiovascular AI imaging, announces its participation in the American ...

Cleerly, a pioneer in advanced cardiovascular imaging, is thrilled to announce that the American Medical Association (AMA) has approved a CPT Category I code for its AI-QCT advanced plaque ...

Cleerly Unveils Groundbreaking Late-Breaking Clinical Trial Results Demonstrating AI-QCT’s Predictive Power for Women’s Cardiovascular Risk at ACC.25.

Cleerly, a New York-based health tech startup, has raised $192 million in a funding round led by investment firms T. Rowe Price and Fidelity Management & Research Company LLC.

Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company’s AI software aims to identify early stage coronary artery disease, similar to how ...